Atlas Trials

Evaluate Safety, Whole-Body Distribution and Radiation Dosimetry in Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT06359821 · COMPLETED

Trial details

NCT number
NCT06359821
Sponsor
Sichuan University
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Metastatic Prostate Cancer
Start date
2024-05-17
Primary completion
2024-10-14
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.